Mesenchymal stem cell transplantation in T1DM patients: Experience of the endocrinology and diabetology department of Marrakech University Hospital
(2023). Mesenchymal stem cell transplantation in T1DM patients: Experience of the endocrinology and diabetology department of Marrakech University Hospital. EKB Journal Management System, 3(2), -. doi: 10.21608/esdlj.2023.456202
. "Mesenchymal stem cell transplantation in T1DM patients: Experience of the endocrinology and diabetology department of Marrakech University Hospital". EKB Journal Management System, 3, 2, 2023, -. doi: 10.21608/esdlj.2023.456202
(2023). 'Mesenchymal stem cell transplantation in T1DM patients: Experience of the endocrinology and diabetology department of Marrakech University Hospital', EKB Journal Management System, 3(2), pp. -. doi: 10.21608/esdlj.2023.456202
Mesenchymal stem cell transplantation in T1DM patients: Experience of the endocrinology and diabetology department of Marrakech University Hospital. EKB Journal Management System, 2023; 3(2): -. doi: 10.21608/esdlj.2023.456202

Mesenchymal stem cell transplantation in T1DM patients: Experience of the endocrinology and diabetology department of Marrakech University Hospital

Egyptian Society of Diabetes and Lipidology Journal
Volume 3, Issue 2, October 2023    PDF (818.02 K)
Document Type: Abstracts
DOI: 10.21608/esdlj.2023.456202
Abstract
According to many studies, mesenchymal stem cell (MSC) therapy derived from adipose tissue is one of the best therapeutic approaches for the treatment of type 1 diabetes. Indeed, MSCs have several characteristics: ease of harvesting and isolation, abundance, their potential to differentiate into multiple lineages, secretion of various cytokines and growth factors, as well as their immunomodulatory effects. 
Statistics
Article View: 33
PDF Download: 14